PCR Tech and IT retail, distribution and vendor news
Ivanti has released its Ivanti Neurons for Patch Intelligence and Ivanti Neurons for Spend Intelligence. These solutions join the company’s Neurons hyper-automation platform, first announced in July 2020, designed to autonomously self-heal and self-secure devices and self-service end users.
The new Ivanti Neurons capabilities help enable users to reduce their time-to-patch for an overall improved security posture. They also dramatically improve the asset deployment and reclamation process for IT operations and security teams to take action and collaboratively work. New Ivanti Neurons solutions and capabilities include:
Ivanti Neurons for Patch Intelligence helps organisations to achieve faster SLAs for their vulnerability remediation efforts via supervised and unsupervised machine learning algorithms. It helps users easily research, prioritise and receive better insights for patch management processes in one central location. Patch reliability data is automatically delivered with actionable intelligence pulled from thousands of public and crowdsourced sentiment data. This information provides improved patch reliability so security teams can act on threats faster and reduce their time-to-patch. A precise picture of the organisation’s threat landscape is provided through prioritised, risk-based metrics and compliance dashboards
Ivanti Neurons for Spend Intelligence, helps improve operational speed and asset visibility, improve utilisation and manage costs. Unlike complex software licensing tools, Ivanti Neurons for Spend Intelligence is easy and intuitive to use, with faster time-to-value. Within minutes, a detailed analysis of usage, licenses types, purchases, subscriptions, renewals and instances are presented in engaging dashboards to help users more effectively track usage, purchase history, upcoming renewals, contract expirations, and ongoing overall spend. Potential under and overspend issues and opportunities for automated reclamation are also highlighted, managing cost and reducing risk.
Read the latest edition of PCR’s monthly magazine below:
